Navigation Links
Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis

Dial-in information: North America (toll free): 1-866-713-8310 International: 1-617-597-5308 Enter passcode: 82004406

The call will be available for replay until Wednesday, July 5, 2007 by calling 1-888-286-8010 (North America) or 1-617-801-6888 (International) and entering the pass code 55009709. A live webcast will also be available to all interested parties on Aspreva's website: http://www.aspreva.com. Please click on the "Webcasts and Events" link under the Investors section of Aspreva's website. A replay of the webcast will be available until the Company's second quarter 2007 conference call.

About CellCept

CellCept (mycophenolate mofetil, MMF) is an immunosuppressant or anti-rejection drug approved for use in combination with other immunosuppressive drugs (cyclosporine and corticosteroids) for the prevention of rejection in patients receiving kidney, heart and liver transplants. There are no adequate and well-controlled studies in pregnant women. As CellCept has been shown to have teratogenic effects in animals at subclinical doses on a body surface area basis, it may cause fetal harm when administered to a pregnant woman. CellCept should not be used in pregnant women unless the potential benefit justifies the potential risk to the fetus. Women of childbearing potential should have a negative serum or urine pregnancy test with a sensitivity of at least 50 mIU/mL within one week prior to beginning therapy even where there has been a history of infertility, unless due to hysterectomy. Women of childbearing potential must use effective contraception before beginning CellCept therapy, during therapy and for six weeks following discontinuation of therapy. Two reliable forms of contraception must be used simultaneously unless abstinence is the chosen method. If pregnancy occurs during treatment, the physician and patient should discuss the desirability of continuing the
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
2. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study

Post Your Comments:
(Date:11/6/2009)...TON, Pa., Nov. 6 In consultation w...cNeil Consumer Healthcare, Division of McNEIL-PPC,...ed number of product lots of TYLENOL® Arthrit...tive red EZ-OPEN CAP. McNeil is initiating the rec... taste associated with these lots that led to a sm...
(Date:11/6/2009)... Repossessions and liquidations of... quarter of 2009 declined as compared to similar f...ment,s NasTrac Quarterly Index (NQI). The figures...oth repossessions and orderly liquidations, also i...tion and printing equipment, offering mixed news o...
(Date:11/6/2009)...6 Derma Sciences, Inc....ced wound care products, announced plans to releas...Monday, November 16, 2009. The Company will hold a...lts at 11:00 am EST. Interested parties should cal...ernational), with passcode 81416481 to access the ...
Breaking Medicine Technology:McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 3NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 4Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2New research discovers link between smoking and brain damage 49757 1New research discovers link between smoking and brain damage 49757 2NIH expands Human Microbiome Project 3B funds sequencing centers and disease projects 8963 1NIH expands Human Microbiome Project 3B funds sequencing centers and disease projects 8963 2NIH expands Human Microbiome Project 3B funds sequencing centers and disease projects 8963 3NIH expands Human Microbiome Project 3B funds sequencing centers and disease projects 8963 4NIH expands Human Microbiome Project 3B funds sequencing centers and disease projects 8963 5Saint Vincent Health Center Ensures Regulatory Compliance with SIS 49754 1Saint Vincent Health Center Ensures Regulatory Compliance with SIS 49754 2Saint Vincent Health Center Ensures Regulatory Compliance with SIS 49754 3
...inger, MD, PhD ,Contributing Editor ,Harvard M...Aspergillus represent two of the most important c...n virtually every environment, and hospitals are n...s of vaginitis ( Candida ) and pulmonary hypersens...m these localized conditions, but by virtue of int...
... M.D. Contributing Editor Clinical guidelines from...emergency medicine have all emphasized the importa... acute myocardial infarction. The measurement of ...e fraction of patients presenting with acute coron... About 30% of patients previously considered to h...
Other Medicine Technology:New Assays to Detect Disseminated Fungal Infections 2New Assays to Detect Disseminated Fungal Infections 3Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results 2Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results 3
(Date:11/8/2009)...n the battle is won," said Dr. Charmaine Yoest. ,... In a vote of 240-194, the Stupak-Ellsworth-Pitts-...ibit abortion mandates and funding in HR 3962 pass...Life Action President and CEO Dr. Charmaine Yoest ...for the pro-life Americans across this country who...
(Date:11/8/2009)...f H.R. 3961 to Secure the Stability of Medicare ,...atement Attributable to: J. James Rohack, M.D., Pr...: http://www.newscom.com/cgi-bin/prnh/20081209/A... House health reform bill, which will help improve... calls for swift passage of H.R. 3961 to secure th...
(Date:11/8/2009)...e of Health Care Reform Bill ,, Critical legi...e for all Americans ,, BALTIMORE, Nov. 7 /PRNe...d States House of Representatives passed critical ...en Medicare for seniors and end discrimination by ...ans out of affordable health coverage. ,, The A...
(Date:11/7/2009)...re-USNewswire/ -- The American Medical Association...for Citizenship and Community Service to Manus C. ...The award recognizes physicians who have gone abov...ke an outstanding public service contribution to t... today during the opening session of the 2009 Inte...
(Date:11/7/2009)...e-USNewswire/ -- Members of the AMA are trying a l...tion rescinding the AMA,s support of HR 3962. ,...ponsible to their PATIENTS, not the leadership of ...for the Association of American Physicians and Sur...r medical groups. ,, "If the AMA leadership ig...
Breaking Medicine News(10 mins):Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2
...30,000 men in the United States who undergo surger...cancer return.// However a recent study shows that...from radiation therapy if their cancer returns . ...py when their cancer came back. Researchers found ...
...M), or middle ear infection, is the most common ba...nly treated with antibiotics.// Millions of child...biotics for ear infections. Children who are given...ction. According to the new guidelines by The A...
...earchers have found that certain hormones in the b...of cardiovascular // events and death in people wi...apparent at levels well below the current standard...c substances and compared the findings to each per...
... reduce their risk of birth defects. Now, new rese...ts alive.// Researchers say about 31,000 stroke-re...d deaths may have been prevented each year since f... heart disease. Specialists from the Centers for D...
...use of antibacterial products, such as soaps, hous...ce the risk of infectious// disease symptoms in th...studied 224 households in New York with at least o...nts and the second group was given identical-looki...
...rinking extra fluids may do more harm than good fo...archers examined results from previous studies to ...y infections drink more fluids is safe. Previous d.... Thus, researchers say giving extra fluids may le...
Other Medicine News:
GORE-TEX ACUSEAL Cardiovascular Patch
...ues for vascular surgery, and the accompanying nee...ialized types of graft be developed. Grafts must n...so available in varying sizes and configurations f...ft has long been the prosthetic of choice among va...
...ar Graft, the newest vascular graft offering from ...ical products for more than two decades, redefines...sion problems that can lead to complications post...its of a ring graft without the rings. Employing ...
... necessary in cruciate ligament reconstruction pro...the bone surface. This condition, if not rectified...replacement. The GORE SMOOTHER Crucial Tool is des...on procedures. The tool functions as both a trial ...
Medicine Products: